Squamous NSCLC

Cancer Immunotherapy: Evolving Treatment Options in Squamous NSCLC

September 14, 2015

Clinical Articles

Activation of T-cell function has become a main focus of immunotherapeutic approaches aimed at enhancing an anticancer immune response and suppressing mechanisms used by tumor cells for immune evasion.

Evolving Paradigms in Squamous NSCLC: Conclusion

September 14, 2015

Clinical Articles

Squamous cell lung cancer represents a distinct molecular pathologic NSCLC with unmet therapeutic needs, especially after failure of first-line platinum-based doublet chemotherapy.